The women’s health market is estimated to have a global value of $48.2bn. Although currently largely concentrated in the US, Europe is fast catching up.
Women’s health holds immense potential, yet glaring health inequalities between the sexes persist. Research published by McKinsey and the World Economic Forum in 2024 identifies disparities across the entire care pathway, from prevention to treatment and follow-up care. And the gaps extend beyond care delivery, encompassing the research, data, and investment that underpin it.
Read our series of reports
Mills & Reeve is hosting a series of roundtable events around the country focusing on how each of these gaps can be addressed to overcome the barriers to better health outcomes for women.
Bringing together key stakeholders from across the science, healthcare services, policy, business and investment sectors, each event will explore a key issue facing women's health:
- investment and support
- research and data
- policy and strategy
Part 1: Investment opportunities
At the end of last year, in Manchester, Mills & Reeve hosted a roundtable focused on investment, and how the city and the wider North West is championing women’s health businesses through funding, partnerships and support.
Whilst the outlook might seem gloomy, part one of the series outlines the key discussions of that afternoon and focuses on the opportunities and barriers to financial investment.
